Skip to content

Clinical trials

Phase 2 Cachexia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cachexia Phase: Phase 2 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20051
20073
20081
20111
20122
20141
20181
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Bristol-Myers Squibb1
Celgene Corporation1
Charles Drew University of Medicine and Science1
Daiichi Sankyo1
Endevica Bio1
Endo USA Inc., a Keenova Therapeutics Company1
GTx1
GlaxoSmithKline1
Helsinn Therapeutics (U.S.), Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cachexia21
Anorexia8
Weight Loss6
Colorectal Neoplasms4
HIV Infections4
Pancreatic Neoplasms4
Acquired Immunodeficiency Syndrome3
Pulmonary Disease, Chronic Obstructive3
Carcinoma, Non-Small-Cell Lung2
Emaciation2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.